Oral administration of live Bifidobacterium substrains isolated from healthy centenarians enhanced immune function in BALB/c mice.
Generally, there is an age-related decline in the human gut titer of Bifidobacterium species, but the titer in healthy centenarians was previously reported to be comparable to that found in much younger people. We addressed whether elevated Bifidobacterium titers relate positively to immune function. This study evaluated the immunoactivities of 2 Bifidobacterium strains (B adolescentis BBMN23 and B longum BBMN68) isolated from healthy centenarians in China. Different dosages (2 x 10(11), 2 x 10(9), or 2 x 10(7) colony-forming units [CFU]/kg body weight) of live bifidobacteria were orally administered once per day to healthy BALB/c mice, and the control group was given sterile skim milk every day. After 4 weeks, the immune parameters including cellular immunity (delayed-type hypersensitivity [DTH], and splenic lymphocyte proliferation), humoral immunity (serum hemolytic activity in immunized animals), and nonspecific immunity (peritoneal macrophages phagocytsis natural killer [NK] cell activity) were measured. We report that both Bifidobacterium strains independently increased the DTH response. Macrophage phagocytosis was also enhanced, while activities of the NK cells and levels of the serum hemolysin also were significantly higher than in the control group. There was a significant increase in splenic lymphocyte proliferation in bifidobacteria treatment animals compared to controls. In conclusion, ingestion of B. adolescentis BBMN23 and B. longum BBMN68 can enhance both innate and acquired immunity in healthy specific pathogen-free (SPF) mice and strains of bifidobacteria from healthy centenarians in Bama longevity villages in China may possess potentially valuable immunomodulatory properties.
College of Food Science and Nutritional Engineering, China Agricultural University, PO Box 303, Beijing 100083, China.
Hai-Ying
HY
Yang
Song-Ling
SL
Liu
Salam A
SA
Ibrahim
Liang
L
Zhao
Jing-Li
JL
Jiang
Wen-Feng
WF
Sun
Fa-Zheng
FZ
Ren
D000284:Administration, Oral; D000369:Aged, 80 and over; D000818:Animals; D001644:Bifidobacterium / Q000145:classification / Q000276:immunology*; D002681:China; D005243:Feces / Q000382:microbiology; D006460:Hemolysin Proteins / Q000097:blood*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007694:Killer Cells, Natural / Q000378:metabolism*; D008214:Lymphocytes / Q000378:metabolism*; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010587:Phagocytosis / Q000502:physiology; D019936:Probiotics / Q000008:administration & dosage / Q000494:pharmacology*
D006460:Hemolysin Proteins